Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?

Pharmacogenomics. 2014 May;15(7):897-900. doi: 10.2217/pgs.14.60.
No abstract available

Keywords: adverse drug reactions; bendamustine; chronic lymphocytic leukemia; cyclophosphamide; fludarabine; personalized medicine; pharmacogenomics.

Publication types

  • Editorial

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Pharmacogenetics*

Substances

  • Cyclophosphamide